The share price of BioPlus Acquisition Corp. (BIOS) now
What analysts predict: $20
52-week High/Low: $10.97 / $9.9
50/200 Day Moving Average:
$10.47 / $10.26
This figure corresponds to the Average Price over the previous 50/200 days.
For BioPlus Acquisition stocks, the 50-day moving average is the support level today.
For BioPlus Acquisition stocks, the 200-day moving average is the support level today.
Are you interested in BioPlus Acquisition Corp. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the BioPlus Acquisition
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one BioPlus Acquisition share be worth in
2023 - 2027?
When should I take profit in BioPlus Acquisition stock?
When should I record a loss on BioPlus Acquisition stock?
What are analysts' forecasts for BioPlus Acquisition stock?
What is the future of BioPlus Acquisition stock?
We forecast BioPlus Acquisition stock performance using neural networks based on historical data on BioPlus Acquisition stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BioPlus Acquisition stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioPlus Acquisition shares. This happens once a day.
Historical and forecast chart of BioPlus Acquisition stock
The chart below shows the historical price of BioPlus Acquisition stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the BioPlus Acquisition stock price can be found in the table below.
Long-term forecasts by years.
BioPlus Acquisition daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Jun 10
10.45
10.32
10.66
3.35
Jun 11
10.58
10.48
10.68
1.96
Jun 12
10.23
10.07
10.31
2.43
Jun 13
10.23
10.09
10.44
3.43
Jun 14
10.26
10.00
10.54
5.34
Jun 15
10.62
10.30
10.86
5.41
Jun 16
10.45
10.23
10.63
3.96
Jun 17
10.52
10.24
10.70
4.41
Jun 18
10.56
10.46
10.83
3.49
Jun 19
10.49
10.22
10.64
4.14
Jun 20
10.42
10.29
10.52
2.19
Jun 21
10.57
10.28
10.78
4.88
Jun 22
10.59
10.33
10.68
3.43
Jun 23
10.73
10.47
11.00
5.10
Jun 24
10.85
10.55
11.08
5.04
Jun 25
10.87
10.71
10.97
2.35
Jun 26
10.98
10.80
11.30
4.64
Jun 27
11.39
11.18
11.50
2.86
Jun 28
11.14
11.03
11.40
3.42
Jun 29
11.18
11.10
11.43
3.02
Jun 30
11.24
11.08
11.42
3.04
Jul 01
10.93
10.69
11.03
3.18
Jul 02
10.86
10.58
11.00
3.94
Jul 03
10.65
10.52
10.92
3.81
Jul 04
11.04
10.77
11.19
3.98
Jul 05
11.45
11.27
11.64
3.24
Jul 06
11.56
11.29
11.78
4.40
Jul 07
11.34
11.01
11.62
5.52
Jul 08
11.10
10.98
11.35
3.34
Jul 09
11.29
11.12
11.51
3.47
BioPlus Acquisition Daily Price Targets
BioPlus Acquisition Stock Forecast 06-10-2023.
Forecast target price for 06-10-2023: $10.45. Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.239%. Pessimistic target level: 10.32 Optimistic target level: 10.66
BioPlus Acquisition Stock Forecast 06-11-2023.
Forecast target price for 06-11-2023: $10.58. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 1.920%. Pessimistic target level: 10.48 Optimistic target level: 10.68
BioPlus Acquisition Stock Forecast 06-12-2023.
Forecast target price for 06-12-2023: $10.23. Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.374%. Pessimistic target level: 10.07 Optimistic target level: 10.31
BioPlus Acquisition Stock Forecast 06-13-2023.
Forecast target price for 06-13-2023: $10.23. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.314%. Pessimistic target level: 10.09 Optimistic target level: 10.44
BioPlus Acquisition Stock Forecast 06-14-2023.
Forecast target price for 06-14-2023: $10.26. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 5.069%. Pessimistic target level: 10.00 Optimistic target level: 10.54
BioPlus Acquisition Stock Forecast 06-15-2023.
Forecast target price for 06-15-2023: $10.62. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 5.130%. Pessimistic target level: 10.30 Optimistic target level: 10.86
BioPlus Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 11, 2021 and is headquartered in New York, NY.
BioPlus Acquisition Address
260 MADISON AVENUE, SUITE 800, NEW YORK, NY, US
Market Capitalization:
308 927 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA:
- $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio:
65.88
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
0.16
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
N/A
Trailing PE:
65.88
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
-
Enterprise Value (EV) /Revenue
EV To EBITDA:
-
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
23560000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website